Cambrian Capital Partners logo

Cambrian Capital Partners

North America, Alberta, Canada, Edmonton

Description

Cambrian Capital Partners is a firm focused on providing off-market and creative investment solutions.

Investor Profile

Cambrian Capital Partners has backed more than 2 startups, with 1 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Diagnostics, Life Science.

Stage Focus

  • Seed (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Diagnostics
  • Life Science
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Cambrian Capital Partners frequently co-invest with?

LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 1
MBX Capital
North America, New York, United States, New York
Co-Investments: 1
HonorHealth
North America, Arizona, United States, Scottsdale
Co-Investments: 2
Top Corner Capital
North America, California, United States, Burlingame
Co-Investments: 1
TV
North America, New York, United States, New York
Co-Investments: 1
BlueStone Venture Partners
North America, Arizona, United States, Tucson
Co-Investments: 1

Which angels does Cambrian Capital Partners often collaborate with?

PH
North America, United States
Shared Deals: 1

What are some of recent deals done by Cambrian Capital Partners?

Journey Live

New York, New York, United States

Journey Live offers a preventative mental health solution to reduce turnover, tackle burnout, and help employees live healthier lives.

FitnessHealth CareMental HealthWellness
Series AJul 25, 2025
Amount Raised: $8,000,000
CND Life Sciences

Scottsdale, Arizona, United States

CND Life Sciences is a life sciences company that develops an evidence-based tool for detecting neurodegenerative diseases.

BiotechnologyHealth DiagnosticsLife ScienceMedical
Series AMay 1, 2025
Amount Raised: $13,500,000
CND Life Sciences

Scottsdale, Arizona, United States

CND Life Sciences develops an evidence-based tool to help confirm a diagnosis of synucleinopathy.

BiotechnologyHealth DiagnosticsLife Science
SeedFeb 1, 2022
Amount Raised: $5,000,000